Clarity to present at three world leading conferences
Sydney, Australia 3 May 2024 Highlights Eight abstracts have been accepted by the American Urological Association (AUA), American Society of Clinical Oncology (ASCO) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Annual Meetings, showcasing the latest data from Clarity’s oncology portfolio. Abstracts of Clarity’s diagnostic clinical trials COBRA and CLARIFY were accepted for…